vs

Side-by-side financial comparison of 3D SYSTEMS CORP (DDD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

3D SYSTEMS CORP is the larger business by last-quarter revenue ($106.3M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). 3D SYSTEMS CORP runs the higher net margin — -18.4% vs -38.1%, a 19.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -4.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 1.6%).

3D Systems Corporation is an American company based in Rock Hill, South Carolina, that engineers, manufactures, and sells 3D printers, 3D printing materials, 3D printed parts, and application engineering services. The company creates product concept models, precision and functional prototypes, master patterns for tooling, as well as production parts for direct digital manufacturing. It uses proprietary processes to fabricate physical objects using input from computer-aided design and manufact...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DDD vs PRCT — Head-to-Head

Bigger by revenue
DDD
DDD
1.3× larger
DDD
$106.3M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+24.5% gap
PRCT
20.2%
-4.3%
DDD
Higher net margin
DDD
DDD
19.7% more per $
DDD
-18.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
1.6%
DDD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DDD
DDD
PRCT
PRCT
Revenue
$106.3M
$83.1M
Net Profit
$-19.5M
$-31.6M
Gross Margin
30.8%
64.9%
Operating Margin
-21.3%
-4.1%
Net Margin
-18.4%
-38.1%
Revenue YoY
-4.3%
20.2%
Net Profit YoY
41.7%
-27.9%
EPS (diluted)
$0.04
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDD
DDD
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$106.3M
$76.4M
Q3 25
$91.2M
$83.3M
Q2 25
$94.8M
$79.2M
Q1 25
$94.5M
$69.2M
Q4 24
$111.0M
$68.2M
Q3 24
$112.9M
$58.4M
Q2 24
$113.3M
$53.4M
Net Profit
DDD
DDD
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-19.5M
$-29.8M
Q3 25
$-18.1M
$-21.4M
Q2 25
$104.4M
$-19.6M
Q1 25
$-37.0M
$-24.7M
Q4 24
$-33.5M
$-18.9M
Q3 24
$-178.6M
$-21.0M
Q2 24
$-27.3M
$-25.6M
Gross Margin
DDD
DDD
PRCT
PRCT
Q1 26
64.9%
Q4 25
30.8%
60.6%
Q3 25
32.3%
64.8%
Q2 25
38.1%
65.4%
Q1 25
34.6%
63.9%
Q4 24
31.0%
64.0%
Q3 24
36.9%
63.2%
Q2 24
41.6%
59.0%
Operating Margin
DDD
DDD
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-21.3%
-40.6%
Q3 25
-23.4%
-27.8%
Q2 25
-16.2%
-28.0%
Q1 25
-38.9%
-39.7%
Q4 24
-27.4%
-28.9%
Q3 24
-160.0%
-38.4%
Q2 24
-23.3%
-50.3%
Net Margin
DDD
DDD
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-18.4%
-39.1%
Q3 25
-19.8%
-25.7%
Q2 25
110.1%
-24.7%
Q1 25
-39.1%
-35.8%
Q4 24
-30.1%
-27.6%
Q3 24
-158.2%
-35.9%
Q2 24
-24.1%
-48.0%
EPS (diluted)
DDD
DDD
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.04
$-0.54
Q3 25
$-0.14
$-0.38
Q2 25
$0.57
$-0.35
Q1 25
$-0.28
$-0.45
Q4 24
$-0.26
$-0.34
Q3 24
$-1.35
$-0.40
Q2 24
$-0.21
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDD
DDD
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$95.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$240.4M
$347.7M
Total Assets
$521.7M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDD
DDD
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$95.6M
$286.5M
Q3 25
$95.5M
$294.3M
Q2 25
$116.4M
$302.7M
Q1 25
$135.0M
$316.2M
Q4 24
$171.3M
$333.7M
Q3 24
$190.0M
$196.8M
Q2 24
$192.7M
$214.1M
Total Debt
DDD
DDD
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
DDD
DDD
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$240.4M
$365.9M
Q3 25
$221.1M
$380.3M
Q2 25
$241.2M
$385.8M
Q1 25
$145.6M
$389.2M
Q4 24
$176.2M
$402.2M
Q3 24
$218.0M
$241.2M
Q2 24
$381.7M
$251.8M
Total Assets
DDD
DDD
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$521.7M
$508.1M
Q3 25
$554.5M
$511.5M
Q2 25
$587.8M
$513.1M
Q1 25
$583.4M
$519.4M
Q4 24
$608.8M
$534.0M
Q3 24
$658.3M
$374.1M
Q2 24
$821.5M
$374.4M
Debt / Equity
DDD
DDD
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDD
DDD
PRCT
PRCT
Operating Cash FlowLast quarter
$-14.7M
Free Cash FlowOCF − Capex
$-16.6M
FCF MarginFCF / Revenue
-15.7%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-97.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDD
DDD
PRCT
PRCT
Q1 26
Q4 25
$-14.7M
$-10.3M
Q3 25
$-13.5M
$-6.6M
Q2 25
$-25.8M
$-15.0M
Q1 25
$-33.8M
$-17.0M
Q4 24
$-7.8M
$-32.4M
Q3 24
$-801.0K
$-18.8M
Q2 24
$-10.8M
$-15.7M
Free Cash Flow
DDD
DDD
PRCT
PRCT
Q1 26
Q4 25
$-16.6M
$-12.2M
Q3 25
$-15.8M
$-9.5M
Q2 25
$-28.8M
$-17.8M
Q1 25
$-36.6M
$-18.8M
Q4 24
$-13.1M
$-33.6M
Q3 24
$-4.4M
$-19.0M
Q2 24
$-14.7M
$-16.8M
FCF Margin
DDD
DDD
PRCT
PRCT
Q1 26
Q4 25
-15.7%
-15.9%
Q3 25
-17.3%
-11.4%
Q2 25
-30.4%
-22.5%
Q1 25
-38.7%
-27.2%
Q4 24
-11.8%
-49.2%
Q3 24
-3.9%
-32.6%
Q2 24
-13.0%
-31.4%
Capex Intensity
DDD
DDD
PRCT
PRCT
Q1 26
Q4 25
1.8%
2.4%
Q3 25
2.5%
3.4%
Q2 25
3.1%
3.5%
Q1 25
3.0%
2.7%
Q4 24
4.8%
1.7%
Q3 24
3.2%
0.4%
Q2 24
3.5%
2.0%
Cash Conversion
DDD
DDD
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
-0.25×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DDD
DDD

Products$62.6M59%
Services$43.7M41%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons